Midostaurin is a new drug used for the treatment of:
Midostaurin : Multitargeted protein kinase inhibitor indicated along with standard cytarabine and daunorubicin for adult with newly diagnosed Acute Myeloid Leukemia (AML) who are FLT3 mutation positive.
CML
ALL
AML
CLL
JIPMER 2017